Published online Nov 27, 2020. doi: 10.4331/wjbc.v11.i3.112
Peer-review started: April 26, 2020
First decision: June 7, 2020
Revised: August 24, 2020
Accepted: September 25, 2020
Article in press: September 25, 2020
Published online: November 27, 2020
Processing time: 198 Days and 18.4 Hours
Escherichia coli (E. coli) isolates are the main pathogens in urinary tract infections (UTIs). Their effect is more important in kidney transplant patients (KTPs). Based on several studies and documents, the frequency of E. coli resistant to common drugs is increasing. Their resistance to antimicrobial drugs is mediated by different mechanisms such as producing extended-spectrum beta-lactamase (ESBLs). Therefore, UTIs caused by ESBL-producing E. coli in KTPs is an important challenge in healthcare settings.
However, different studies have reported the frequency of ESBLs E. coli isolates from different origins in Iran, but there are few studies on their frequency and role in KTPs and their antimicrobial susceptibility profile.
The aims of this study were: (1) To estimate the prevalence of ESBL-producing E. coli in KTPs; (2) To serotype the ESBL-producing E. coli; and (3) To identify the antibacterial susceptibility patterns of isolated bacteria in Tehran, Iran.
Bacterial culture and isolation based on standard bacteriologic methods were carried out. Antimicrobial susceptibility testing based on the Clinical Laboratory and Standards Institute was performed. The minimum inhibitory concentration was determined using Epsilon strips during the E-test. The frequency of genes responsible for ESBLs coding was assessed after DNA extraction and polymerase chain reaction. Statistical analysis of the data was performed.
The most important findings were: (1) The frequency of ESBL-producing E. coli in KTPs was found to be 33.4%; (2) High resistance rates to ampicillin (86%) and cefotaxime (80%) were documented; (3) The most frequent serotype was serotype I (50%); (4) The most frequently found related gene was blaTEM (55%); and (5) All of the E. coli isolates were susceptible to doripenem and ertapenem.
Further efforts to control ESBL-producing E. coli isolates should include the careful use of all antibiotics as well as barrier precautions to reduce their spread.
More E. coli isolates from different parts of Iran should be obtained and their antimicrobial profiles evaluated. Also, the frequency of ESBLs production and the existence of other ESBLs genes such as KPC and metalo-betalactamases should be determined.